Ubiquitin-independent proteasomal degradation during oncogenic viral infections.
about
Consensus on the role of human cytomegalovirus in glioblastomaThe Proteasome Subunit Rpn8 Interacts with the Small Nucleolar RNA Protein (snoRNP) Assembly Protein Pih1 and Mediates Its Ubiquitin-independent Degradation in Saccharomyces cerevisiae.BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infectionThe carboxyl-terminal tail of Noxa protein regulates the stability of Noxa and Mcl-1The 19S proteasome activator promotes human cytomegalovirus immediate early gene expression through proteolytic and nonproteolytic mechanisms.Regulating the 20S proteasome ubiquitin-independent degradation pathway.Proteasome-dependent disruption of the E3 ubiquitin ligase anaphase-promoting complex by HCMV protein pUL21a.Increased S-nitrosylation and proteasomal degradation of caspase-3 during infection contribute to the persistence of adherent invasive Escherichia coli (AIEC) in immune cellsProline-mediated proteasomal degradation of the prostate-specific tumor suppressor NKX3.1.Ubiquitin-independent proteasomal degradation of tumor suppressors by human cytomegalovirus pp71 requires the 19S regulatory particleTale of a tegument transactivator: the past, present and future of human CMV pp71Roles of the two distinct proteasome pathways in hepatitis C virus infection.Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samplesTuning the proteasome to brighten the end of the journey.Mass Spectrometry: A Technique of Many Faces.Human Antiviral Protein IFIX Suppresses Viral Gene Expression during Herpes Simplex Virus 1 (HSV-1) Infection and Is Counteracted by Virus-induced Proteasomal Degradation.Regulation of cell surface protease receptor S100A10 by retinoic acid therapy in acute promyelocytic leukemia (APL)
P2860
Q24632103-0012BA31-D357-49CE-BD6F-C7A456201A7DQ27937923-B52BED12-E6C7-46B4-A57F-8F3D8A7196C4Q30519179-3A50A62C-7442-4E1C-B17F-F7A872EB3675Q33793022-771A465A-DB13-4CF0-9E12-33F5472360FBQ34261453-C19A63E6-7DE2-4472-A64A-548BC0F11FF5Q34318192-FD0ABCDF-DCF3-46C6-A440-9DA502D79914Q34335500-FF746FA1-949D-4F72-90BF-EEB1D432A523Q34827418-7850CA75-A27A-4CDA-ACB1-A802C22568ACQ36332904-8C0A78F9-5982-4135-9755-D1187F26B782Q36760210-CC323F77-B575-4CA8-9919-B6AA469F1805Q38078937-46705B59-C54C-418B-84EB-69EB49033DDBQ38156851-B8863BF9-83EB-4644-A7C0-756C543FC0FDQ38407022-8BBBB19B-B0E8-47B9-8BDD-F21F64CAABE6Q38559265-557419B8-F038-4EC1-A6A6-2E447CCC5528Q39094217-FF313F3C-4148-4055-9C24-25B6F0A8EDE2Q40376097-EC9E83C8-3783-42B0-9847-267517B3693FQ58751591-C10386F6-9488-4308-AEB7-27219728E43B
P2860
Ubiquitin-independent proteasomal degradation during oncogenic viral infections.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Ubiquitin-independent proteasomal degradation during oncogenic viral infections.
@ast
Ubiquitin-independent proteasomal degradation during oncogenic viral infections.
@en
type
label
Ubiquitin-independent proteasomal degradation during oncogenic viral infections.
@ast
Ubiquitin-independent proteasomal degradation during oncogenic viral infections.
@en
prefLabel
Ubiquitin-independent proteasomal degradation during oncogenic viral infections.
@ast
Ubiquitin-independent proteasomal degradation during oncogenic viral infections.
@en
P2093
P2860
P1476
Ubiquitin-independent proteasomal degradation during oncogenic viral infections.
@en
P2093
Jiwon Hwang
Laura Winkler
Robert F Kalejta
P2860
P304
P356
10.1016/J.BBCAN.2011.05.005
P407
P577
2011-06-06T00:00:00Z